Can clinical outputs predict BDNF levels in people with Parkinson’s disease?
Objective: To modelling the relationship between Brain-Derived Neurotrophic Factor (BDNF) levels and clinical variables (stages of disease and cognition) in people with Parkinson's disease (PD).…The dual cognitive syndrome in Parkinson’s disease: volumetric, morphological and tractometric features
Objective: To assess volumetric, morphological and tractometric features associated with the fronto-striatal and posterior cortical cognitive profiles in Parkinson’s Disease (PD) Background: The dual syndrome…Parkinson’s disease patients at Hoehn and Yahr stage 1 show deficits in reactive but not proactive inhibitory control
Objective: We wanted to assess whether i) Parkinson’s disease (PD) patients at Hoehn and Yahr (HY) stage 1 show a global or a selective impairment…Anxiety disorders are associated with verbal memory impairment in Parkinson’s disease
Objective: The present study aimed to investigate the association between anxiety disorders and memory impairment in Parkinson’s disease.The present study aimed to investigate the association…The role of attention networks in walking in Parkinson’s disease
Objective: To better understand how different attention networks contribute to walking. Background: Parkinson’s disease (PD) is often characterized by effortful, fall-prone walking. PD can also…Impact of Obstructive Sleep Apnea on Cognitive and Motor Functions in Parkinson’s Disease Patients
Objective: We conducted this systematic review and meta-analysis to assess the impact of OSA on cognitive and motor disorders in PD patients. Background: Parkinson’s disease…Deep brain stimulation and cognitive decline in Parkinson’s disease: The predictive value of Alternate Fluency test
Objective: To study the impact of subthalamic nucleus deep brain stimulation (STN-DBS) on executive function using Alternate Fluency Test (AFT) and to investigate predictors for…The interplay between asymmetric dopaminergic degeneration, brain structural changes and cognition in de-novo PD: The PPMI dataset
Objective: To characterize the impact of asymmetric dopaminergic degeneration, measured with I123-ioflupane SPECT (DATSCAN), on cortical integrity and cognitive deficits, in de-novo right-handed PD patients.…Modifiable Comorbidities Associated with Rate of Cognitive Decline in Parkinson’s Disease
Objective: To determine the association between baseline modifiable comorbidities, including cardiovascular disease risk factors, mood disorders, and sleep characteristics, and the rate of change in…Regional cortical thickness alterations in PD patients with cognitive impairment
Objective: To evaluate the cortical thickness alterations in cognitively impaired patients with PD (PD-CI) in a comparative study with cognitively normal patients with PD (PD-CN)…
- « Previous Page
- 1
- …
- 792
- 793
- 794
- 795
- 796
- …
- 1554
- Next Page »